×
0.000518739463104737 0.000389054597328506 -0.000389054597328506 0.000518739463104737 -0.00155621838931384 -0.00414991570483716 -0.00564129166126316 -0.016599662819349
Stockreport

Express Scripts on board with Novo's Ozempic; shares ahead 2% [Seeking Alpha]

EXPRESS SCRIPTS (ESRX)  More Company Research Source: Seeking Alpha
Last express scripts earnings: 8/1 04:01 pm Check Earnings Report
PDF Express Scripts on board with Novo's Ozempic; shares ahead 2%Novo Nordisk (NVO+2%) is up more than a 40% spike in volume on the heels of the news that Express Scripts has added once-weekly type 2 diabetes med Ozempic (semaglutide) to its 2018 formulary, thereby establishing head-to-head competition with Eli Lilly's once-weekly Trulicity (dulaglutide), a situation enthusiastically embraced by the price hawkish pharmacy benefit manager.According toReuters, a Novo spokesperson stated that inclusion in Express Scripts' formulary should give Ozempic a "single-digit share" of the overall GLP-1 market in the U.S.Both products will also compete against AstraZeneca's once-weekly BYDUREON (exenatide).See all stocks on the move »Now read:Novo Nordisk: Obesity Crisis Could Be Profitable » [Read more]

IMPACT SNAPSHOT EVENT TIME: ESRX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ESRX alerts
from News Quantified
Opt-in for
ESRX alerts

from News Quantified
Opt-in for
ESRX alerts

from News Quantified